Visiomed (France) Today
| ALVMG Stock | EUR 0.19 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Visiomed is selling at 0.19 as of the 5th of May 2024; that is No Change since the beginning of the trading day. The stock's last reported lowest price was 0.19. Visiomed has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Visiomed Group are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 16th of May 2022 and ending today, the 5th of May 2024. Click here to learn more.
Visiomed Group SA develops and distributes electronic medical devices in Europe and internationally. Visiomed Group SA was founded in 2006 and is based in Paris, France. VISIOMED GROUP operates under Medical Devices classification in France and is traded on Paris Stock Exchange. The company has 294.27 M outstanding shares. More on Visiomed Group
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Visiomed Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Visiomed's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Visiomed or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) |
Visiomed Group (ALVMG) is traded on Euronext Paris in France and employs 67 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 96.52 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Visiomed's market, we take the total number of its shares issued and multiply it by Visiomed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Visiomed Group operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 294.27 M outstanding shares.
Visiomed Group has accumulated about 7 K in cash with (6.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check Visiomed Probability Of Bankruptcy
Ownership AllocationVisiomed Group shows a total of 294.27 Million outstanding shares. About 97.0 % of Visiomed outstanding shares are held by general public with 2.92 % by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Visiomed Ownership Details
Visiomed Stock Price Odds Analysis
In regard to a normal probability distribution, the odds of Visiomed jumping above the current price in 90 days from now is under 95%. The Visiomed Group probability density function shows the probability of Visiomed stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Visiomed Group has a beta of -0.2919. This suggests as returns on the benchmark increase, returns on holding Visiomed are expected to decrease at a much lower rate. During a bear market, however, Visiomed Group is likely to outperform the market. Additionally, visiomed Group has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Visiomed to move above the current price in 90 days from now is under 95 (This Visiomed Group probability density function shows the probability of Visiomed Stock to fall within a particular range of prices over 90 days) .
Visiomed Group Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Visiomed market risk premium is the additional return an investor will receive from holding Visiomed long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Visiomed. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Visiomed's alpha and beta are two of the key measurements used to evaluate Visiomed's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.16 | |||
| Standard Deviation | 3.43 | |||
| Variance | 11.79 | |||
| Risk Adjusted Performance | (0.05) |
Visiomed Stock Against Markets
Picking the right benchmark for Visiomed stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Visiomed stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Visiomed is critical whether you are bullish or bearish towards Visiomed Group at a given time. Please also check how Visiomed's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Visiomed without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
How to buy Visiomed Stock?
Before investing in Visiomed, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Visiomed. To buy Visiomed stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Visiomed. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Visiomed stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Visiomed Group stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Visiomed Group stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Visiomed Group, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Visiomed Group?
The danger of trading Visiomed Group is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Visiomed is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Visiomed. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Visiomed Group is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Visiomed Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Visiomed Group information on this page should be used as a complementary analysis to other Visiomed's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Visiomed Stock analysis
When running Visiomed's price analysis, check to measure Visiomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Visiomed is operating at the current time. Most of Visiomed's value examination focuses on studying past and present price action to predict the probability of Visiomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Visiomed's price. Additionally, you may evaluate how the addition of Visiomed to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |